SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-000383
Filing Date
2019-02-08
Accepted
2019-02-08 16:01:14
Documents
67
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 476252
2 CERTIFICATION ipix_ex311.htm EX-31.1 7993
3 CERTIFICATION ipix_ex312.htm EX-31.2 8137
4 CERTIFICATION ipix_ex321.htm EX-32.1 2834
5 CERTIFICATION ipix_ex322.htm EX-32.2 3025
  Complete submission text file 0001477932-19-000383.txt   3977560

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipix-20181231.xml EX-101.INS 742968
7 XBRL TAXONOMY EXTENSION SCHEMA ipix-20181231.xsd EX-101.SCH 57289
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20181231_cal.xml EX-101.CAL 48533
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20181231_def.xml EX-101.DEF 246603
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20181231_lab.xml EX-101.LAB 284903
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20181231_pre.xml EX-101.PRE 314204
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 19579813
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1